Document Detail


Cytochrome P450 II D6 gene polymorphisms and the neuroleptic-induced extrapyramidal symptoms in Japanese schizophrenic patients.
MedLine Citation:
PMID:  12960748     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: The purpose of this study was to examine whether the neuroleptic-induced extrapyramidal symptoms are associated with the CYP2D6 activity. METHODS: The CYP2D6 gene polymorphisms (CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*10, and CYP2D6*12) were genotyped in 196 normal controls and 320 schizophrenic patients receiving neuroleptics. The relationships with susceptibility to extrapyramidal symptoms (EPS) and tardive dyskinesia, and with steady-state serum haloperidol levels in maintenance therapy, were investigated. RESULTS: The allele frequency of CYP2D6*2 was significantly higher, while that of CYP2D6*10 tended to be higher in the schizophrenic patients susceptible to acute EPS. The steady-state serum haloperidol levels per daily dosage were observed to be significantly higher in schizophrenic patients with the mutant-type homozygote of CYP2D6*2, while this difference was trend level in those of CYP2D6*10. However, no significant difference was observed in the distribution of both CYP2D6*2 (C2938T) and CYP2D6*10 (C188T) polymorphisms between schizophrenic patients with or without tardive dyskinesia. CONCLUSION: The present results suggest that the homozygotes of CYP2D6*2 and CYP2D6*10 appear to be a susceptibility factor for developing acute EPS in schizophrenic patients and for impaired neuroleptic metabolism in Japanese schizophrenic patients.
Authors:
Toshiya Inada; Hisashi Senoo; Yoshimi Iijima; Tadamitsu Yamauchi; Gohei Yagi
Related Documents :
3626198 - Chilaiditi's syndrome in schizophrenic patients.
18587278 - The history of artistic creativity in psychotic patients.
1224018 - Serotonin (5ht) systems in psychotic states.
8579808 - Reduced frontal and occipital lobe asymmetry on the ct-scans of schizophrenic patients....
2653418 - Does vitreous fluorophotometry reflect severity of early diabetic retinopathy?
15966188 - Hyperamylasemia induced by percutaneous papillary balloon dilatation for symptomatic ch...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Psychiatric genetics     Volume:  13     ISSN:  0955-8829     ISO Abbreviation:  Psychiatr. Genet.     Publication Date:  2003 Sep 
Date Detail:
Created Date:  2003-09-08     Completed Date:  2004-05-05     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9106748     Medline TA:  Psychiatr Genet     Country:  England    
Other Details:
Languages:  eng     Pagination:  163-8     Citation Subset:  IM    
Affiliation:
National Institute of Mental Health, National Center of Neurology and Psychiatry, Chiba, Japan. inada@med.nagoya-u.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antipsychotic Agents / adverse effects*
Basal Ganglia Diseases / chemically induced,  genetics*
Cytochrome P-450 CYP2D6 / genetics*
Gene Frequency
Genetic Predisposition to Disease / genetics
Homozygote
Humans
Japan
Polymorphism, Genetic / genetics*
Reference Values
Schizophrenia / enzymology,  genetics*
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; EC 1.14.14.1/Cytochrome P-450 CYP2D6

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Confirmation of alcohol preference quantitative trait loci in the replicate high alcohol drinking an...
Next Document:  A genetic association study of the mu opioid receptor and severe opioid dependence.